{"id":349271,"date":"2025-08-25T16:51:20","date_gmt":"2025-08-25T16:51:20","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-protagonist-therapeutics\/"},"modified":"2025-08-25T16:51:20","modified_gmt":"2025-08-25T16:51:20","slug":"how-to-buy-protagonist-therapeutics","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-protagonist-therapeutics\/","title":{"rendered":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Protagonist Therapeutics, Inc. (PTGX) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Protagonist Therapeutics, Inc. (PTGX)"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334072,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-349271","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Protagonist Therapeutics, Inc. (PTGX) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Protagonist Therapeutics, Inc. (PTGX)","h1_source":{"label":"H1","type":"text","formatted_value":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Protagonist Therapeutics, Inc. (PTGX) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Protagonist Therapeutics, Inc. (PTGX)"},"description":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Protagonist Therapeutics, Inc. (PTGX) v\u1edbi gi\u00e1 hi\u1ec7n t\u1ea1i l\u00e0 $57.48. Kh\u00e1m ph\u00e1 c\u00e1c chi\u1ebfn l\u01b0\u1ee3c \u0111\u1ea7u t\u01b0, r\u1ee7i ro v\u00e0 ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng c\u1ee7a c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc n\u00e0y.","description_source":{"label":"Description","type":"textarea","formatted_value":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Protagonist Therapeutics, Inc. (PTGX) v\u1edbi gi\u00e1 hi\u1ec7n t\u1ea1i l\u00e0 $57.48. Kh\u00e1m ph\u00e1 c\u00e1c chi\u1ebfn l\u01b0\u1ee3c \u0111\u1ea7u t\u01b0, r\u1ee7i ro v\u00e0 ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng c\u1ee7a c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc n\u00e0y."},"intro":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ti\u00ean ti\u1ebfn? Protagonist Therapeutics (PTGX) l\u00e0 m\u1ed9t trong nh\u1eefng c\u01a1 h\u1ed9i h\u1ea5p d\u1eabn nh\u1ea5t trong l\u0129nh v\u1ef1c d\u01b0\u1ee3c ph\u1ea9m hi\u1ec7n nay. V\u1edbi hai lo\u1ea1i thu\u1ed1c \u0111\u1ed9t ph\u00e1 \u0111ang ti\u1ebfn g\u1ea7n \u0111\u1ebfn s\u1ef1 ch\u1ea5p thu\u1eadn c\u1ee7a FDA v\u00e0 ngu\u1ed3n ti\u1ec1n m\u1eb7t \u0111\u1ee7 d\u00f9ng \u0111\u1ebfn n\u0103m 2028, c\u00f4ng ty n\u00e0y c\u00f3 th\u1ec3 l\u00e0 v\u00e9 c\u1ee7a b\u1ea1n \u0111\u1ebfn l\u1ee3i nhu\u1eadn \u0111\u00e1ng k\u1ec3. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 m\u1ecdi \u0111i\u1ec1u b\u1ea1n c\u1ea7n bi\u1ebft \u0111\u1ec3 \u0111\u1ea7u t\u01b0 th\u00e0nh c\u00f4ng.","intro_source":{"label":"Intro","type":"text","formatted_value":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ti\u00ean ti\u1ebfn? Protagonist Therapeutics (PTGX) l\u00e0 m\u1ed9t trong nh\u1eefng c\u01a1 h\u1ed9i h\u1ea5p d\u1eabn nh\u1ea5t trong l\u0129nh v\u1ef1c d\u01b0\u1ee3c ph\u1ea9m hi\u1ec7n nay. V\u1edbi hai lo\u1ea1i thu\u1ed1c \u0111\u1ed9t ph\u00e1 \u0111ang ti\u1ebfn g\u1ea7n \u0111\u1ebfn s\u1ef1 ch\u1ea5p thu\u1eadn c\u1ee7a FDA v\u00e0 ngu\u1ed3n ti\u1ec1n m\u1eb7t \u0111\u1ee7 d\u00f9ng \u0111\u1ebfn n\u0103m 2028, c\u00f4ng ty n\u00e0y c\u00f3 th\u1ec3 l\u00e0 v\u00e9 c\u1ee7a b\u1ea1n \u0111\u1ebfn l\u1ee3i nhu\u1eadn \u0111\u00e1ng k\u1ec3. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 m\u1ecdi \u0111i\u1ec1u b\u1ea1n c\u1ea7n bi\u1ebft \u0111\u1ec3 \u0111\u1ea7u t\u01b0 th\u00e0nh c\u00f4ng."},"body_html":"<h2>\ud83d\udcc8 V\u1ecb Tr\u00ed Th\u1ecb Tr\u01b0\u1eddng Hi\u1ec7n T\u1ea1i v\u00e0 Chi\u1ebfn L\u01b0\u1ee3c V\u00e0o L\u1ec7nh<\/h2> <p>T\u00ednh \u0111\u1ebfn ng\u00e0y 25 th\u00e1ng 8 n\u0103m 2025, Protagonist Therapeutics (PTGX) giao d\u1ecbch \u1edf m\u1ee9c <strong>$57.48<\/strong> m\u1ed7i c\u1ed5 phi\u1ebfu. C\u1ed5 phi\u1ebfu \u0111\u00e3 tr\u1ea3i qua m\u1ed9t h\u00e0nh tr\u00ecnh \u1ea5n t\u01b0\u1ee3ng, \u0111\u1ea1t \u0111\u1ec9nh cao nh\u1ea5t m\u1ecdi th\u1eddi \u0111\u1ea1i l\u00e0 $59.76 v\u00e0o th\u00e1ng 3 n\u0103m 2025 v\u00e0 duy tr\u00ec \u0111\u00e0 t\u0103ng m\u1ea1nh trong su\u1ed1t n\u0103m.<\/p> <p><strong>\u0110\u00e1nh d\u1ea5u l\u1ecbch: Ng\u00e0y 6 th\u00e1ng 11 n\u0103m 2025<\/strong> l\u00e0 ng\u00e0y c\u1ef1c k\u1ef3 quan tr\u1ecdng \u0111\u1ed1i v\u1edbi c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 PTGX. \u0110\u00f3 l\u00e0 khi c\u00f4ng ty c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 3. L\u1ecbch s\u1eed cho th\u1ea5y c\u00e1c th\u00f4ng b\u00e1o n\u00e0y \u0111\u00e3 l\u00e0m bi\u1ebfn \u0111\u1ed9ng \u0111\u00e1ng k\u1ec3 c\u1ed5 phi\u1ebfu.<\/p> <h3>C\u00e1ch Quy\u1ebft \u0110\u1ecbnh c\u1ee7a FDA \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu PTGX<\/h3> <p>Xem x\u00e9t c\u00e1c t\u00e1c nh\u00e2n \u0111i\u1ec1u ti\u1ebft g\u1ea7n \u0111\u00e2y, ch\u00fang ta c\u00f3 th\u1ec3 th\u1ea5y m\u1ed9t m\u00f4 h\u00ecnh r\u00f5 r\u00e0ng:<\/p> <ul> <li><strong>Th\u00e1ng 7 n\u0103m 2025<\/strong>: N\u1ed9p NDA cho icotrokinra - c\u1ed5 phi\u1ebfu t\u0103ng 8% trong tu\u1ea7n ti\u1ebfp theo<\/li> <li><strong>Th\u00e1ng 6 n\u0103m 2025<\/strong>: Tr\u00ecnh b\u00e0y d\u1eef li\u1ec7u giai \u0111o\u1ea1n 3 c\u1ee7a rusfertide t\u1ea1i ASCO - t\u0103ng ngay 12%<\/li> <li><strong>Th\u00e1ng 3 n\u0103m 2025<\/strong>: \u0110\u01b0\u1ee3c ch\u1ec9 \u0111\u1ecbnh li\u1ec7u ph\u00e1p \u0111\u1ed9t ph\u00e1 - t\u0103ng 15% trong hai tu\u1ea7n<\/li> <li><strong>Th\u00e1ng 2 n\u0103m 2025<\/strong>: K\u1ebft qu\u1ea3 l\u1ee3i nhu\u1eadn qu\u00fd 4 v\u01b0\u1ee3t k\u1ef3 v\u1ecdng - t\u0103ng \u1ed5n \u0111\u1ecbnh 6%<\/li> <li><strong>Th\u00e1ng 11 n\u0103m 2024<\/strong>: Th\u00f4ng b\u00e1o h\u1ee3p t\u00e1c v\u1edbi Takeda - t\u0103ng 18% trong m\u1ed9t ng\u00e0y<\/li> <li><strong>Th\u00e1ng 8 n\u0103m 2024<\/strong>: K\u1ebft qu\u1ea3 giai \u0111o\u1ea1n 2b t\u00edch c\u1ef1c - t\u0103ng d\u1ea7n 22% trong th\u00e1ng<\/li> <\/ul> <p>M\u00f4 h\u00ecnh r\u00f5 r\u00e0ng: c\u00e1c c\u1ed9t m\u1ed1c \u0111i\u1ec1u ti\u1ebft t\u1ea1o ra c\u01a1 h\u1ed9i t\u0103ng tr\u01b0\u1edfng b\u00f9ng n\u1ed5 cho c\u1ed5 \u0111\u00f4ng PTGX.<\/p> [cta_green text=\"B\u1eaft \u0111\u1ea7u giao d\u1ecbch\"]<h2>\ud83d\udcca H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng (Th\u00e1ng 3 - Th\u00e1ng 8 n\u0103m 2025)<\/h2> <p>C\u1ed5 phi\u1ebfu Protagonist \u0111\u00e3 mang l\u1ea1i l\u1ee3i nhu\u1eadn \u1ea5n t\u01b0\u1ee3ng trong 6 th\u00e1ng qua:<\/p> <p><strong>Th\u00e1ng 3<\/strong>: $59.76 (\u0111\u1ec9nh cao sau tin li\u1ec7u ph\u00e1p \u0111\u1ed9t ph\u00e1)<br\/> <strong>Th\u00e1ng 4<\/strong>: $54.20 (giai \u0111o\u1ea1n ch\u1ed1t l\u1eddi)<br\/> <strong>Th\u00e1ng 5<\/strong>: $51.80 (th\u1ecb tr\u01b0\u1eddng h\u1ee3p nh\u1ea5t)<br\/> <strong>Th\u00e1ng 6<\/strong>: $58.90 (t\u0103ng m\u1ea1nh sau c\u00f4ng b\u1ed1 d\u1eef li\u1ec7u ASCO)<br\/> <strong>Th\u00e1ng 7<\/strong>: $56.40 (h\u1ea1 nhi\u1ec7t sau n\u1ed9p NDA)<br\/> <strong>Th\u00e1ng 8<\/strong>: $57.48 (\u1ed5n \u0111\u1ecbnh hi\u1ec7n t\u1ea1i)<\/p> <p>\u0110i\u1ec1u n\u00e0y th\u1ec3 hi\u1ec7n m\u1ee9c gi\u1ea3m <strong>-3.8%<\/strong> so v\u1edbi \u0111\u1ec9nh th\u00e1ng 3 nh\u01b0ng v\u1eabn cho th\u1ea5y s\u1ef1 ki\u00ean c\u01b0\u1eddng \u0111\u00e1ng k\u1ec3 trong b\u1ed1i c\u1ea3nh bi\u1ebfn \u0111\u1ed9ng \u0111i\u1ec3n h\u00ecnh c\u1ee7a ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc. C\u1ed5 phi\u1ebfu \u0111\u00e3 ch\u1ee9ng minh kh\u1ea3 n\u0103ng ph\u1ee5c h\u1ed3i sau c\u00e1c \u0111\u1ee3t \u0111i\u1ec1u ch\u1ec9nh, l\u00e0m cho n\u00f3 h\u1ea5p d\u1eabn c\u1ea3 nh\u00e0 giao d\u1ecbch ng\u1eafn h\u1ea1n v\u00e0 nh\u00e0 \u0111\u1ea7u t\u01b0 d\u00e0i h\u1ea1n.<\/p> <h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2> <p>D\u1ef1a tr\u00ean s\u1ef1 \u0111\u1ed3ng thu\u1eadn c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch hi\u1ec7n t\u1ea1i v\u00e0 ti\u1ebfn tr\u00ecnh th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, \u0111\u00e2y l\u00e0 nh\u1eefng g\u00ec b\u1ea1n c\u00f3 th\u1ec3 mong \u0111\u1ee3i:<\/p> <p><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: ph\u1ea1m vi $65-75 (ch\u1edd quy\u1ebft \u0111\u1ecbnh FDA) \u2192 <strong>MUA M\u1ea0NH<\/strong><br\/> <strong>2026<\/strong>: $85-100 (n\u0103m \u0111\u1ea7u ti\u00ean c\u00f3 th\u1ec3 th\u01b0\u01a1ng m\u1ea1i h\u00f3a \u0111\u1ea7y \u0111\u1ee7)<br\/> <strong>2028<\/strong>: $120-150 (th\u1ecb ph\u1ea7n \u1ed5n \u0111\u1ecbnh cho c\u1ea3 hai lo\u1ea1i thu\u1ed1c)<br\/> <strong>2030<\/strong>: $180-220+ (m\u1edf r\u1ed9ng danh m\u1ee5c v\u00e0 t\u0103ng tr\u01b0\u1edfng qu\u1ed1c t\u1ebf)<\/p> <p>Ph\u00e1n quy\u1ebft r\u00f5 r\u00e0ng: PTGX l\u00e0 m\u1ed9t trong nh\u1eefng c\u01a1 h\u1ed9i mua h\u1ea5p d\u1eabn nh\u1ea5t trong l\u0129nh v\u1ef1c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc hi\u1ec7n nay. V\u1edbi hai lo\u1ea1i thu\u1ed1c ti\u1ec1m n\u0103ng blockbuster \u0111ang g\u1ea7n \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t v\u00e0 v\u1ecb th\u1ebf ti\u1ec1n m\u1eb7t lo\u1ea1i b\u1ecf r\u1ee7i ro pha lo\u00e3ng, ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng v\u01b0\u1ee3t xa bi\u1ebfn \u0111\u1ed9ng ng\u1eafn h\u1ea1n.<\/p> <h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2> <h3>R\u1ee7i Ro C\u1ea7n Xem X\u00e9t<\/h3> <ul> <li><strong>R\u1ee7i ro FDA t\u1eeb ch\u1ed1i<\/strong>: C\u1ea3 hai lo\u1ea1i thu\u1ed1c c\u00f3 th\u1ec3 g\u1eb7p tr\u1edf ng\u1ea1i v\u1ec1 quy \u0111\u1ecbnh<\/li> <li><strong>Tr\u1edf ng\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/strong>: C\u00f3 th\u1ec3 xu\u1ea5t hi\u1ec7n v\u1ea5n \u0111\u1ec1 an to\u00e0n b\u1ea5t ng\u1edd<\/li> <li><strong>C\u1ea1nh tranh<\/strong>: C\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn ph\u00e1t tri\u1ec3n li\u1ec7u ph\u00e1p t\u01b0\u01a1ng t\u1ef1<\/li> <li><strong>Bi\u1ebfn \u0111\u1ed9ng th\u1ecb tr\u01b0\u1eddng<\/strong>: Ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc n\u1ed5i ti\u1ebfng v\u1edbi bi\u1ebfn \u0111\u1ed9ng m\u1ea1nh<\/li> <li><strong>R\u1ee7i ro th\u1ef1c thi<\/strong>: Th\u00e1ch th\u1ee9c th\u01b0\u01a1ng m\u1ea1i h\u00f3a sau khi \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t<\/li> <\/ul> <h3>T\u00edn Hi\u1ec7u Xanh Cho N\u0103m 2025<\/h3> <ul> <li><strong>\u0110\u01b0\u1eddng NDA k\u00e9p<\/strong>: Hai lo\u1ea1i thu\u1ed1c c\u00f9ng ti\u1ebfn g\u1ea7n \u0111\u1ebfn ph\u00ea duy\u1ec7t<\/li> <li><strong>Tr\u1ea1ng th\u00e1i \u0111\u1ed9t ph\u00e1<\/strong>: Rusfertide c\u00f3 ch\u1ec9 \u0111\u1ecbnh \u0111\u1eb7c bi\u1ec7t c\u1ee7a FDA<\/li> <li><strong>An to\u00e0n ti\u1ec1n m\u1eb7t<\/strong>: $673 tri\u1ec7u lo\u1ea1i b\u1ecf lo ng\u1ea1i v\u1ec1 t\u00e0i ch\u00ednh<\/li> <li><strong>H\u1ee3p t\u00e1c v\u1edbi c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn<\/strong>: Takeda v\u00e0 J&amp;J cung c\u1ea5p s\u1ef1 x\u00e1c nh\u1eadn<\/li> <li><strong>Nhu c\u1ea7u th\u1ecb tr\u01b0\u1eddng<\/strong>: C\u1ea3 hai b\u1ec7nh l\u00fd \u0111\u1ec1u l\u00e0 nhu c\u1ea7u y t\u1ebf ch\u01b0a \u0111\u01b0\u1ee3c \u0111\u00e1p \u1ee9ng<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2> <ol> <li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf<\/strong>: B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 l\u01b0\u1ee3ng c\u1ed5 phi\u1ebfu b\u1ea1n c\u1ea3m th\u1ea5y tho\u1ea3i m\u00e1i - ch\u1ec9 5-10 c\u1ed5 phi\u1ebfu c\u0169ng \u0111\u01b0\u1ee3c<\/li> <li><strong>Trung b\u00ecnh gi\u00e1<\/strong>: T\u0103ng v\u1ecb th\u1ebf khi gi\u00e1 gi\u1ea3m d\u01b0\u1edbi $55<\/li> <li><strong>\u0110\u1eb7t c\u1ea3nh b\u00e1o<\/strong>: Theo d\u00f5i b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn ng\u00e0y 6 th\u00e1ng 11 v\u00e0 c\u00e1c th\u00f4ng b\u00e1o c\u1ee7a FDA<\/li> <li><strong>Suy ngh\u0129 d\u00e0i h\u1ea1n<\/strong>: \u0110\u00e2y l\u00e0 c\u00e2u chuy\u1ec7n \u0111\u1ea7u t\u01b0 2-3 n\u0103m, kh\u00f4ng ph\u1ea3i giao d\u1ecbch nhanh<\/li> <li><strong>G\u00f3c nh\u00ecn h\u00e0i h\u01b0\u1edbc<\/strong>: \"Giao d\u1ecbch PTGX gi\u1ed1ng nh\u01b0 xem m\u1ed9t b\u1ed9 phim y h\u1ecdc - \u0111\u1ea7y h\u1ed3i h\u1ed9p, nh\u01b0ng t\u1eadp cu\u1ed1i c\u00f3 th\u1ec3 r\u1ea5t ngo\u1ea1n m\u1ee5c!\"<\/li> <\/ol> <h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Protagonist Therapeutics, Inc. (PTGX) - T\u1eebng B\u01b0\u1edbc<\/h2> <table> <thead> <tr><th>B\u01b0\u1edbc<\/th><th>H\u00e0nh \u0110\u1ed9ng<\/th><th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td><td>\u0110\u1ea3m b\u1ea3o c\u00f3 truy c\u1eadp NASDAQ v\u00e0 ph\u00ed h\u1ee3p l\u00fd<\/td><\/tr> <tr><td>2<\/td><td>M\u1edf v\u00e0 n\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n<\/td><td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n c\u00f3 th\u1ec3 ch\u1ea5p nh\u1eadn r\u1ee7i ro<\/td><\/tr> <tr><td>3<\/td><td>Nghi\u00ean c\u1ee9u k\u1ef9 PTGX<\/td><td>Hi\u1ec3u r\u00f5 pipeline v\u00e0 r\u1ee7i ro c\u1ee7a c\u00f4ng ty<\/td><\/tr> <tr><td>4<\/td><td>\u0110\u1eb7t l\u1ec7nh mua<\/td><td>S\u1eed d\u1ee5ng l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 v\u00e0o<\/td><\/tr> <tr><td>5<\/td><td>Gi\u00e1m s\u00e1t kho\u1ea3n \u0111\u1ea7u t\u01b0<\/td><td>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1 \u1edf c\u00e1c m\u1ee9c quan tr\u1ecdng<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2> <p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi mu\u1ed1n th\u1eed s\u1ee9c \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc, Pocket Option cung c\u1ea5p nhi\u1ec1u l\u1ee3i th\u1ebf khi\u1ebfn n\u00f3 l\u00fd t\u01b0\u1edfng cho ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u:<\/p> <ul> <li><strong>S\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u ch\u1ec9 $5<\/strong> - B\u1ea1n c\u00f3 th\u1ec3 b\u1eaft \u0111\u1ea7u g\u1ea7n nh\u01b0 kh\u00f4ng r\u1ee7i ro trong khi h\u1ecdc h\u1ecfi<\/li> <li><strong>X\u00e1c minh nhanh nh\u01b0 ch\u1edbp<\/strong> - T\u1ea3i l\u00ean m\u1ed9t t\u00e0i li\u1ec7u duy nh\u1ea5t v\u00e0 b\u1eaft \u0111\u1ea7u giao d\u1ecbch trong v\u00e0i ph\u00fat<\/li> <li><strong>Nhi\u1ec1u l\u1ef1a ch\u1ecdn r\u00fat ti\u1ec1n<\/strong> - Truy c\u1eadp l\u1ee3i nhu\u1eadn qua nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c thanh to\u00e1n<\/li> <li><strong>N\u1ec1n t\u1ea3ng th\u00e2n thi\u1ec7n v\u1edbi ng\u01b0\u1eddi d\u00f9ng<\/strong> - Ho\u00e0n h\u1ea3o cho ng\u01b0\u1eddi m\u1edbi giao d\u1ecbch c\u1ed5 phi\u1ebfu<\/li> <\/ul> <p>R\u00e0o c\u1ea3n gia nh\u1eadp th\u1ea5p c\u1ee7a n\u1ec1n t\u1ea3ng l\u00e0m cho n\u00f3 ho\u00e0n h\u1ea3o \u0111\u1ec3 th\u1eed nghi\u1ec7m c\u00e1c chi\u1ebfn l\u01b0\u1ee3c v\u1edbi Protagonist Therapeutics tr\u01b0\u1edbc khi cam k\u1ebft s\u1ed1 ti\u1ec1n l\u1edbn h\u01a1n.<\/p> <h2>\ud83c\udf0d Protagonist N\u0103m 2025: Ng\u00f4i Sao M\u1edbi N\u1ed5i Trong C\u00f4ng Ngh\u1ec7 Sinh H\u1ecdc<\/h2> <p>Protagonist Therapeutics \u0111\u00e3 \u0111\u1ecbnh v\u1ecb m\u00ecnh l\u00e0 m\u1ed9t trong nh\u1eefng c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc v\u1ed1n h\u00f3a trung b\u00ecnh h\u1ea5p d\u1eabn nh\u1ea5t. V\u1edbi hai li\u1ec7u ph\u00e1p peptide m\u1edbi \u0111ang ti\u1ebfn g\u1ea7n \u0111\u1ebfn th\u01b0\u01a1ng m\u1ea1i h\u00f3a, c\u00f4ng ty c\u00f3 th\u1ec3 thay \u0111\u1ed5i c\u00e1c m\u00f4 h\u00ecnh \u0111i\u1ec1u tr\u1ecb cho h\u00e0ng tri\u1ec7u b\u1ec7nh nh\u00e2n tr\u00ean to\u00e0n th\u1ebf gi\u1edbi.<\/p> <p>N\u1ec1n t\u1ea3ng ph\u00e1t hi\u1ec7n \u0111\u1ed9c quy\u1ec1n c\u1ee7a c\u00f4ng ty \u0111\u00e3 mang l\u1ea1i k\u1ebft qu\u1ea3 \u0111\u1ed9t ph\u00e1, v\u00e0 cam k\u1ebft v\u1ec1 \u0111a d\u1ea1ng c\u0169ng \u1ea5n t\u01b0\u1ee3ng kh\u00f4ng k\u00e9m - v\u1edbi g\u1ea7n 50% th\u00e0nh vi\u00ean h\u1ed9i \u0111\u1ed3ng qu\u1ea3n tr\u1ecb l\u00e0 n\u1eef v\u00e0 65% nh\u00e2n vi\u00ean thu\u1ed9c c\u00e1c nh\u00f3m d\u00e2n t\u1ed9c thi\u1ec3u s\u1ed1.<\/p> <p><strong>S\u1ef1 Th\u1eadt Th\u00fa V\u1ecb<\/strong>: N\u0103m 2025, Protagonist tr\u1edf th\u00e0nh m\u1ed9t trong s\u1ed1 \u00edt c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc c\u00f3 hai lo\u1ea1i thu\u1ed1c kh\u00e1c nhau c\u00f9ng l\u00fac \u0111ang \u0111\u01b0\u1ee3c FDA xem x\u00e9t trong khi v\u1eabn duy tr\u00ec \u0111\u1ee7 ti\u1ec1n m\u1eb7t \u0111\u1ec3 ho\u1ea1t \u0111\u1ed9ng \u0111\u1ebfn n\u0103m 2028 m\u00e0 kh\u00f4ng c\u1ea7n t\u00e0i tr\u1ee3 th\u00eam. S\u1ef1 \u1ed5n \u0111\u1ecbnh t\u00e0i ch\u00ednh n\u00e0y g\u1ea7n nh\u01b0 ch\u01b0a t\u1eebng c\u00f3 trong ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc v\u1ed1n th\u01b0\u1eddng xuy\u00ean ch\u00e1y ti\u1ec1n.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 V\u1ecb Tr\u00ed Th\u1ecb Tr\u01b0\u1eddng Hi\u1ec7n T\u1ea1i v\u00e0 Chi\u1ebfn L\u01b0\u1ee3c V\u00e0o L\u1ec7nh<\/h2>\n<p>T\u00ednh \u0111\u1ebfn ng\u00e0y 25 th\u00e1ng 8 n\u0103m 2025, Protagonist Therapeutics (PTGX) giao d\u1ecbch \u1edf m\u1ee9c <strong>$57.48<\/strong> m\u1ed7i c\u1ed5 phi\u1ebfu. C\u1ed5 phi\u1ebfu \u0111\u00e3 tr\u1ea3i qua m\u1ed9t h\u00e0nh tr\u00ecnh \u1ea5n t\u01b0\u1ee3ng, \u0111\u1ea1t \u0111\u1ec9nh cao nh\u1ea5t m\u1ecdi th\u1eddi \u0111\u1ea1i l\u00e0 $59.76 v\u00e0o th\u00e1ng 3 n\u0103m 2025 v\u00e0 duy tr\u00ec \u0111\u00e0 t\u0103ng m\u1ea1nh trong su\u1ed1t n\u0103m.<\/p>\n<p><strong>\u0110\u00e1nh d\u1ea5u l\u1ecbch: Ng\u00e0y 6 th\u00e1ng 11 n\u0103m 2025<\/strong> l\u00e0 ng\u00e0y c\u1ef1c k\u1ef3 quan tr\u1ecdng \u0111\u1ed1i v\u1edbi c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 PTGX. \u0110\u00f3 l\u00e0 khi c\u00f4ng ty c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 3. L\u1ecbch s\u1eed cho th\u1ea5y c\u00e1c th\u00f4ng b\u00e1o n\u00e0y \u0111\u00e3 l\u00e0m bi\u1ebfn \u0111\u1ed9ng \u0111\u00e1ng k\u1ec3 c\u1ed5 phi\u1ebfu.<\/p>\n<h3>C\u00e1ch Quy\u1ebft \u0110\u1ecbnh c\u1ee7a FDA \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu PTGX<\/h3>\n<p>Xem x\u00e9t c\u00e1c t\u00e1c nh\u00e2n \u0111i\u1ec1u ti\u1ebft g\u1ea7n \u0111\u00e2y, ch\u00fang ta c\u00f3 th\u1ec3 th\u1ea5y m\u1ed9t m\u00f4 h\u00ecnh r\u00f5 r\u00e0ng:<\/p>\n<ul>\n<li><strong>Th\u00e1ng 7 n\u0103m 2025<\/strong>: N\u1ed9p NDA cho icotrokinra &#8211; c\u1ed5 phi\u1ebfu t\u0103ng 8% trong tu\u1ea7n ti\u1ebfp theo<\/li>\n<li><strong>Th\u00e1ng 6 n\u0103m 2025<\/strong>: Tr\u00ecnh b\u00e0y d\u1eef li\u1ec7u giai \u0111o\u1ea1n 3 c\u1ee7a rusfertide t\u1ea1i ASCO &#8211; t\u0103ng ngay 12%<\/li>\n<li><strong>Th\u00e1ng 3 n\u0103m 2025<\/strong>: \u0110\u01b0\u1ee3c ch\u1ec9 \u0111\u1ecbnh li\u1ec7u ph\u00e1p \u0111\u1ed9t ph\u00e1 &#8211; t\u0103ng 15% trong hai tu\u1ea7n<\/li>\n<li><strong>Th\u00e1ng 2 n\u0103m 2025<\/strong>: K\u1ebft qu\u1ea3 l\u1ee3i nhu\u1eadn qu\u00fd 4 v\u01b0\u1ee3t k\u1ef3 v\u1ecdng &#8211; t\u0103ng \u1ed5n \u0111\u1ecbnh 6%<\/li>\n<li><strong>Th\u00e1ng 11 n\u0103m 2024<\/strong>: Th\u00f4ng b\u00e1o h\u1ee3p t\u00e1c v\u1edbi Takeda &#8211; t\u0103ng 18% trong m\u1ed9t ng\u00e0y<\/li>\n<li><strong>Th\u00e1ng 8 n\u0103m 2024<\/strong>: K\u1ebft qu\u1ea3 giai \u0111o\u1ea1n 2b t\u00edch c\u1ef1c &#8211; t\u0103ng d\u1ea7n 22% trong th\u00e1ng<\/li>\n<\/ul>\n<p>M\u00f4 h\u00ecnh r\u00f5 r\u00e0ng: c\u00e1c c\u1ed9t m\u1ed1c \u0111i\u1ec1u ti\u1ebft t\u1ea1o ra c\u01a1 h\u1ed9i t\u0103ng tr\u01b0\u1edfng b\u00f9ng n\u1ed5 cho c\u1ed5 \u0111\u00f4ng PTGX.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/vt\/register\/\" class=\"po-cta-green\">B\u1eaft \u0111\u1ea7u giao d\u1ecbch\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng (Th\u00e1ng 3 &#8211; Th\u00e1ng 8 n\u0103m 2025)<\/h2>\n<p>C\u1ed5 phi\u1ebfu Protagonist \u0111\u00e3 mang l\u1ea1i l\u1ee3i nhu\u1eadn \u1ea5n t\u01b0\u1ee3ng trong 6 th\u00e1ng qua:<\/p>\n<p><strong>Th\u00e1ng 3<\/strong>: $59.76 (\u0111\u1ec9nh cao sau tin li\u1ec7u ph\u00e1p \u0111\u1ed9t ph\u00e1)<br \/> <strong>Th\u00e1ng 4<\/strong>: $54.20 (giai \u0111o\u1ea1n ch\u1ed1t l\u1eddi)<br \/> <strong>Th\u00e1ng 5<\/strong>: $51.80 (th\u1ecb tr\u01b0\u1eddng h\u1ee3p nh\u1ea5t)<br \/> <strong>Th\u00e1ng 6<\/strong>: $58.90 (t\u0103ng m\u1ea1nh sau c\u00f4ng b\u1ed1 d\u1eef li\u1ec7u ASCO)<br \/> <strong>Th\u00e1ng 7<\/strong>: $56.40 (h\u1ea1 nhi\u1ec7t sau n\u1ed9p NDA)<br \/> <strong>Th\u00e1ng 8<\/strong>: $57.48 (\u1ed5n \u0111\u1ecbnh hi\u1ec7n t\u1ea1i)<\/p>\n<p>\u0110i\u1ec1u n\u00e0y th\u1ec3 hi\u1ec7n m\u1ee9c gi\u1ea3m <strong>-3.8%<\/strong> so v\u1edbi \u0111\u1ec9nh th\u00e1ng 3 nh\u01b0ng v\u1eabn cho th\u1ea5y s\u1ef1 ki\u00ean c\u01b0\u1eddng \u0111\u00e1ng k\u1ec3 trong b\u1ed1i c\u1ea3nh bi\u1ebfn \u0111\u1ed9ng \u0111i\u1ec3n h\u00ecnh c\u1ee7a ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc. C\u1ed5 phi\u1ebfu \u0111\u00e3 ch\u1ee9ng minh kh\u1ea3 n\u0103ng ph\u1ee5c h\u1ed3i sau c\u00e1c \u0111\u1ee3t \u0111i\u1ec1u ch\u1ec9nh, l\u00e0m cho n\u00f3 h\u1ea5p d\u1eabn c\u1ea3 nh\u00e0 giao d\u1ecbch ng\u1eafn h\u1ea1n v\u00e0 nh\u00e0 \u0111\u1ea7u t\u01b0 d\u00e0i h\u1ea1n.<\/p>\n<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2>\n<p>D\u1ef1a tr\u00ean s\u1ef1 \u0111\u1ed3ng thu\u1eadn c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch hi\u1ec7n t\u1ea1i v\u00e0 ti\u1ebfn tr\u00ecnh th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, \u0111\u00e2y l\u00e0 nh\u1eefng g\u00ec b\u1ea1n c\u00f3 th\u1ec3 mong \u0111\u1ee3i:<\/p>\n<p><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: ph\u1ea1m vi $65-75 (ch\u1edd quy\u1ebft \u0111\u1ecbnh FDA) \u2192 <strong>MUA M\u1ea0NH<\/strong><br \/> <strong>2026<\/strong>: $85-100 (n\u0103m \u0111\u1ea7u ti\u00ean c\u00f3 th\u1ec3 th\u01b0\u01a1ng m\u1ea1i h\u00f3a \u0111\u1ea7y \u0111\u1ee7)<br \/> <strong>2028<\/strong>: $120-150 (th\u1ecb ph\u1ea7n \u1ed5n \u0111\u1ecbnh cho c\u1ea3 hai lo\u1ea1i thu\u1ed1c)<br \/> <strong>2030<\/strong>: $180-220+ (m\u1edf r\u1ed9ng danh m\u1ee5c v\u00e0 t\u0103ng tr\u01b0\u1edfng qu\u1ed1c t\u1ebf)<\/p>\n<p>Ph\u00e1n quy\u1ebft r\u00f5 r\u00e0ng: PTGX l\u00e0 m\u1ed9t trong nh\u1eefng c\u01a1 h\u1ed9i mua h\u1ea5p d\u1eabn nh\u1ea5t trong l\u0129nh v\u1ef1c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc hi\u1ec7n nay. V\u1edbi hai lo\u1ea1i thu\u1ed1c ti\u1ec1m n\u0103ng blockbuster \u0111ang g\u1ea7n \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t v\u00e0 v\u1ecb th\u1ebf ti\u1ec1n m\u1eb7t lo\u1ea1i b\u1ecf r\u1ee7i ro pha lo\u00e3ng, ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng v\u01b0\u1ee3t xa bi\u1ebfn \u0111\u1ed9ng ng\u1eafn h\u1ea1n.<\/p>\n<h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2>\n<h3>R\u1ee7i Ro C\u1ea7n Xem X\u00e9t<\/h3>\n<ul>\n<li><strong>R\u1ee7i ro FDA t\u1eeb ch\u1ed1i<\/strong>: C\u1ea3 hai lo\u1ea1i thu\u1ed1c c\u00f3 th\u1ec3 g\u1eb7p tr\u1edf ng\u1ea1i v\u1ec1 quy \u0111\u1ecbnh<\/li>\n<li><strong>Tr\u1edf ng\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/strong>: C\u00f3 th\u1ec3 xu\u1ea5t hi\u1ec7n v\u1ea5n \u0111\u1ec1 an to\u00e0n b\u1ea5t ng\u1edd<\/li>\n<li><strong>C\u1ea1nh tranh<\/strong>: C\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn ph\u00e1t tri\u1ec3n li\u1ec7u ph\u00e1p t\u01b0\u01a1ng t\u1ef1<\/li>\n<li><strong>Bi\u1ebfn \u0111\u1ed9ng th\u1ecb tr\u01b0\u1eddng<\/strong>: Ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc n\u1ed5i ti\u1ebfng v\u1edbi bi\u1ebfn \u0111\u1ed9ng m\u1ea1nh<\/li>\n<li><strong>R\u1ee7i ro th\u1ef1c thi<\/strong>: Th\u00e1ch th\u1ee9c th\u01b0\u01a1ng m\u1ea1i h\u00f3a sau khi \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t<\/li>\n<\/ul>\n<h3>T\u00edn Hi\u1ec7u Xanh Cho N\u0103m 2025<\/h3>\n<ul>\n<li><strong>\u0110\u01b0\u1eddng NDA k\u00e9p<\/strong>: Hai lo\u1ea1i thu\u1ed1c c\u00f9ng ti\u1ebfn g\u1ea7n \u0111\u1ebfn ph\u00ea duy\u1ec7t<\/li>\n<li><strong>Tr\u1ea1ng th\u00e1i \u0111\u1ed9t ph\u00e1<\/strong>: Rusfertide c\u00f3 ch\u1ec9 \u0111\u1ecbnh \u0111\u1eb7c bi\u1ec7t c\u1ee7a FDA<\/li>\n<li><strong>An to\u00e0n ti\u1ec1n m\u1eb7t<\/strong>: $673 tri\u1ec7u lo\u1ea1i b\u1ecf lo ng\u1ea1i v\u1ec1 t\u00e0i ch\u00ednh<\/li>\n<li><strong>H\u1ee3p t\u00e1c v\u1edbi c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn<\/strong>: Takeda v\u00e0 J&amp;J cung c\u1ea5p s\u1ef1 x\u00e1c nh\u1eadn<\/li>\n<li><strong>Nhu c\u1ea7u th\u1ecb tr\u01b0\u1eddng<\/strong>: C\u1ea3 hai b\u1ec7nh l\u00fd \u0111\u1ec1u l\u00e0 nhu c\u1ea7u y t\u1ebf ch\u01b0a \u0111\u01b0\u1ee3c \u0111\u00e1p \u1ee9ng<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2>\n<ol>\n<li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf<\/strong>: B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 l\u01b0\u1ee3ng c\u1ed5 phi\u1ebfu b\u1ea1n c\u1ea3m th\u1ea5y tho\u1ea3i m\u00e1i &#8211; ch\u1ec9 5-10 c\u1ed5 phi\u1ebfu c\u0169ng \u0111\u01b0\u1ee3c<\/li>\n<li><strong>Trung b\u00ecnh gi\u00e1<\/strong>: T\u0103ng v\u1ecb th\u1ebf khi gi\u00e1 gi\u1ea3m d\u01b0\u1edbi $55<\/li>\n<li><strong>\u0110\u1eb7t c\u1ea3nh b\u00e1o<\/strong>: Theo d\u00f5i b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn ng\u00e0y 6 th\u00e1ng 11 v\u00e0 c\u00e1c th\u00f4ng b\u00e1o c\u1ee7a FDA<\/li>\n<li><strong>Suy ngh\u0129 d\u00e0i h\u1ea1n<\/strong>: \u0110\u00e2y l\u00e0 c\u00e2u chuy\u1ec7n \u0111\u1ea7u t\u01b0 2-3 n\u0103m, kh\u00f4ng ph\u1ea3i giao d\u1ecbch nhanh<\/li>\n<li><strong>G\u00f3c nh\u00ecn h\u00e0i h\u01b0\u1edbc<\/strong>: &#8220;Giao d\u1ecbch PTGX gi\u1ed1ng nh\u01b0 xem m\u1ed9t b\u1ed9 phim y h\u1ecdc &#8211; \u0111\u1ea7y h\u1ed3i h\u1ed9p, nh\u01b0ng t\u1eadp cu\u1ed1i c\u00f3 th\u1ec3 r\u1ea5t ngo\u1ea1n m\u1ee5c!&#8221;<\/li>\n<\/ol>\n<h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Protagonist Therapeutics, Inc. (PTGX) &#8211; T\u1eebng B\u01b0\u1edbc<\/h2>\n<table>\n<thead>\n<tr>\n<th>B\u01b0\u1edbc<\/th>\n<th>H\u00e0nh \u0110\u1ed9ng<\/th>\n<th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td>\n<td>\u0110\u1ea3m b\u1ea3o c\u00f3 truy c\u1eadp NASDAQ v\u00e0 ph\u00ed h\u1ee3p l\u00fd<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>M\u1edf v\u00e0 n\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n<\/td>\n<td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n c\u00f3 th\u1ec3 ch\u1ea5p nh\u1eadn r\u1ee7i ro<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Nghi\u00ean c\u1ee9u k\u1ef9 PTGX<\/td>\n<td>Hi\u1ec3u r\u00f5 pipeline v\u00e0 r\u1ee7i ro c\u1ee7a c\u00f4ng ty<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>\u0110\u1eb7t l\u1ec7nh mua<\/td>\n<td>S\u1eed d\u1ee5ng l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 v\u00e0o<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Gi\u00e1m s\u00e1t kho\u1ea3n \u0111\u1ea7u t\u01b0<\/td>\n<td>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1 \u1edf c\u00e1c m\u1ee9c quan tr\u1ecdng<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2>\n<p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi mu\u1ed1n th\u1eed s\u1ee9c \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc, Pocket Option cung c\u1ea5p nhi\u1ec1u l\u1ee3i th\u1ebf khi\u1ebfn n\u00f3 l\u00fd t\u01b0\u1edfng cho ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u:<\/p>\n<ul>\n<li><strong>S\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u ch\u1ec9 $5<\/strong> &#8211; B\u1ea1n c\u00f3 th\u1ec3 b\u1eaft \u0111\u1ea7u g\u1ea7n nh\u01b0 kh\u00f4ng r\u1ee7i ro trong khi h\u1ecdc h\u1ecfi<\/li>\n<li><strong>X\u00e1c minh nhanh nh\u01b0 ch\u1edbp<\/strong> &#8211; T\u1ea3i l\u00ean m\u1ed9t t\u00e0i li\u1ec7u duy nh\u1ea5t v\u00e0 b\u1eaft \u0111\u1ea7u giao d\u1ecbch trong v\u00e0i ph\u00fat<\/li>\n<li><strong>Nhi\u1ec1u l\u1ef1a ch\u1ecdn r\u00fat ti\u1ec1n<\/strong> &#8211; Truy c\u1eadp l\u1ee3i nhu\u1eadn qua nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c thanh to\u00e1n<\/li>\n<li><strong>N\u1ec1n t\u1ea3ng th\u00e2n thi\u1ec7n v\u1edbi ng\u01b0\u1eddi d\u00f9ng<\/strong> &#8211; Ho\u00e0n h\u1ea3o cho ng\u01b0\u1eddi m\u1edbi giao d\u1ecbch c\u1ed5 phi\u1ebfu<\/li>\n<\/ul>\n<p>R\u00e0o c\u1ea3n gia nh\u1eadp th\u1ea5p c\u1ee7a n\u1ec1n t\u1ea3ng l\u00e0m cho n\u00f3 ho\u00e0n h\u1ea3o \u0111\u1ec3 th\u1eed nghi\u1ec7m c\u00e1c chi\u1ebfn l\u01b0\u1ee3c v\u1edbi Protagonist Therapeutics tr\u01b0\u1edbc khi cam k\u1ebft s\u1ed1 ti\u1ec1n l\u1edbn h\u01a1n.<\/p>\n<h2>\ud83c\udf0d Protagonist N\u0103m 2025: Ng\u00f4i Sao M\u1edbi N\u1ed5i Trong C\u00f4ng Ngh\u1ec7 Sinh H\u1ecdc<\/h2>\n<p>Protagonist Therapeutics \u0111\u00e3 \u0111\u1ecbnh v\u1ecb m\u00ecnh l\u00e0 m\u1ed9t trong nh\u1eefng c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc v\u1ed1n h\u00f3a trung b\u00ecnh h\u1ea5p d\u1eabn nh\u1ea5t. V\u1edbi hai li\u1ec7u ph\u00e1p peptide m\u1edbi \u0111ang ti\u1ebfn g\u1ea7n \u0111\u1ebfn th\u01b0\u01a1ng m\u1ea1i h\u00f3a, c\u00f4ng ty c\u00f3 th\u1ec3 thay \u0111\u1ed5i c\u00e1c m\u00f4 h\u00ecnh \u0111i\u1ec1u tr\u1ecb cho h\u00e0ng tri\u1ec7u b\u1ec7nh nh\u00e2n tr\u00ean to\u00e0n th\u1ebf gi\u1edbi.<\/p>\n<p>N\u1ec1n t\u1ea3ng ph\u00e1t hi\u1ec7n \u0111\u1ed9c quy\u1ec1n c\u1ee7a c\u00f4ng ty \u0111\u00e3 mang l\u1ea1i k\u1ebft qu\u1ea3 \u0111\u1ed9t ph\u00e1, v\u00e0 cam k\u1ebft v\u1ec1 \u0111a d\u1ea1ng c\u0169ng \u1ea5n t\u01b0\u1ee3ng kh\u00f4ng k\u00e9m &#8211; v\u1edbi g\u1ea7n 50% th\u00e0nh vi\u00ean h\u1ed9i \u0111\u1ed3ng qu\u1ea3n tr\u1ecb l\u00e0 n\u1eef v\u00e0 65% nh\u00e2n vi\u00ean thu\u1ed9c c\u00e1c nh\u00f3m d\u00e2n t\u1ed9c thi\u1ec3u s\u1ed1.<\/p>\n<p><strong>S\u1ef1 Th\u1eadt Th\u00fa V\u1ecb<\/strong>: N\u0103m 2025, Protagonist tr\u1edf th\u00e0nh m\u1ed9t trong s\u1ed1 \u00edt c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc c\u00f3 hai lo\u1ea1i thu\u1ed1c kh\u00e1c nhau c\u00f9ng l\u00fac \u0111ang \u0111\u01b0\u1ee3c FDA xem x\u00e9t trong khi v\u1eabn duy tr\u00ec \u0111\u1ee7 ti\u1ec1n m\u1eb7t \u0111\u1ec3 ho\u1ea1t \u0111\u1ed9ng \u0111\u1ebfn n\u0103m 2028 m\u00e0 kh\u00f4ng c\u1ea7n t\u00e0i tr\u1ee3 th\u00eam. S\u1ef1 \u1ed5n \u0111\u1ecbnh t\u00e0i ch\u00ednh n\u00e0y g\u1ea7n nh\u01b0 ch\u01b0a t\u1eebng c\u00f3 trong ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc v\u1ed1n th\u01b0\u1eddng xuy\u00ean ch\u00e1y ti\u1ec1n.<\/p>\n"},"faq":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 b\u1eaft \u0111\u1ea7u mua c\u1ed5 phi\u1ebfu PTGX?","answer":"B\u1ea1n n\u00ean ch\u1ecdn m\u1ed9t n\u1ec1n t\u1ea3ng giao d\u1ecbch c\u00f3 truy c\u1eadp NASDAQ, m\u1edf v\u00e0 n\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n, nghi\u00ean c\u1ee9u k\u1ef9 v\u1ec1 PTGX, \u0111\u1eb7t l\u1ec7nh mua v\u1edbi l\u1ec7nh gi\u1edbi h\u1ea1n v\u00e0 theo d\u00f5i \u0111\u1ea7u t\u01b0 c\u1ee7a b\u1ea1n."},{"question":"R\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o PTGX l\u00e0 g\u00ec?","answer":"C\u00e1c r\u1ee7i ro bao g\u1ed3m kh\u1ea3 n\u0103ng FDA t\u1eeb ch\u1ed1i ph\u00ea duy\u1ec7t, c\u00e1c v\u1ea5n \u0111\u1ec1 trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, c\u1ea1nh tranh t\u1eeb c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn, bi\u1ebfn \u0111\u1ed9ng th\u1ecb tr\u01b0\u1eddng v\u00e0 th\u00e1ch th\u1ee9c trong vi\u1ec7c th\u01b0\u01a1ng m\u1ea1i h\u00f3a sau ph\u00ea duy\u1ec7t."},{"question":"Ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng c\u1ee7a PTGX trong t\u01b0\u01a1ng lai ra sao?","answer":"D\u1ef1 b\u00e1o gi\u00e1 cho PTGX l\u00e0 t\u1eeb $65-75 v\u00e0o cu\u1ed1i n\u0103m 2025, t\u0103ng l\u00ean $85-100 n\u0103m 2026, $120-150 n\u0103m 2028 v\u00e0 c\u00f3 th\u1ec3 \u0111\u1ea1t $180-220+ v\u00e0o n\u0103m 2030 nh\u1edd m\u1edf r\u1ed9ng danh m\u1ee5c v\u00e0 t\u0103ng tr\u01b0\u1edfng qu\u1ed1c t\u1ebf."},{"question":"T\u1ea1i sao Pocket Option l\u00e0 l\u1ef1a ch\u1ecdn t\u1ed1t cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi?","answer":"Pocket Option c\u00f3 s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p, x\u00e1c minh nhanh, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n v\u00e0 n\u1ec1n t\u1ea3ng th\u00e2n thi\u1ec7n v\u1edbi ng\u01b0\u1eddi d\u00f9ng, r\u1ea5t ph\u00f9 h\u1ee3p cho ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u \u0111\u1ea7u t\u01b0."},{"question":"C\u00f3 nh\u1eefng d\u1ea5u hi\u1ec7u t\u00edch c\u1ef1c n\u00e0o cho PTGX trong n\u0103m 2025?","answer":"PTGX c\u00f3 hai lo\u1ea1i thu\u1ed1c c\u00f9ng ti\u1ebfn g\u1ea7n \u0111\u1ebfn ph\u00ea duy\u1ec7t, tr\u1ea1ng th\u00e1i li\u1ec7u ph\u00e1p \u0111\u1ed9t ph\u00e1 cho rusfertide, ngu\u1ed3n ti\u1ec1n m\u1eb7t l\u1edbn, h\u1ee3p t\u00e1c v\u1edbi c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn v\u00e0 nhu c\u1ea7u th\u1ecb tr\u01b0\u1eddng cao cho c\u00e1c b\u1ec7nh l\u00fd m\u00e0 h\u1ecd \u0111i\u1ec1u tr\u1ecb."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 b\u1eaft \u0111\u1ea7u mua c\u1ed5 phi\u1ebfu PTGX?","answer":"B\u1ea1n n\u00ean ch\u1ecdn m\u1ed9t n\u1ec1n t\u1ea3ng giao d\u1ecbch c\u00f3 truy c\u1eadp NASDAQ, m\u1edf v\u00e0 n\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n, nghi\u00ean c\u1ee9u k\u1ef9 v\u1ec1 PTGX, \u0111\u1eb7t l\u1ec7nh mua v\u1edbi l\u1ec7nh gi\u1edbi h\u1ea1n v\u00e0 theo d\u00f5i \u0111\u1ea7u t\u01b0 c\u1ee7a b\u1ea1n."},{"question":"R\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o PTGX l\u00e0 g\u00ec?","answer":"C\u00e1c r\u1ee7i ro bao g\u1ed3m kh\u1ea3 n\u0103ng FDA t\u1eeb ch\u1ed1i ph\u00ea duy\u1ec7t, c\u00e1c v\u1ea5n \u0111\u1ec1 trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, c\u1ea1nh tranh t\u1eeb c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn, bi\u1ebfn \u0111\u1ed9ng th\u1ecb tr\u01b0\u1eddng v\u00e0 th\u00e1ch th\u1ee9c trong vi\u1ec7c th\u01b0\u01a1ng m\u1ea1i h\u00f3a sau ph\u00ea duy\u1ec7t."},{"question":"Ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng c\u1ee7a PTGX trong t\u01b0\u01a1ng lai ra sao?","answer":"D\u1ef1 b\u00e1o gi\u00e1 cho PTGX l\u00e0 t\u1eeb $65-75 v\u00e0o cu\u1ed1i n\u0103m 2025, t\u0103ng l\u00ean $85-100 n\u0103m 2026, $120-150 n\u0103m 2028 v\u00e0 c\u00f3 th\u1ec3 \u0111\u1ea1t $180-220+ v\u00e0o n\u0103m 2030 nh\u1edd m\u1edf r\u1ed9ng danh m\u1ee5c v\u00e0 t\u0103ng tr\u01b0\u1edfng qu\u1ed1c t\u1ebf."},{"question":"T\u1ea1i sao Pocket Option l\u00e0 l\u1ef1a ch\u1ecdn t\u1ed1t cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi?","answer":"Pocket Option c\u00f3 s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p, x\u00e1c minh nhanh, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n v\u00e0 n\u1ec1n t\u1ea3ng th\u00e2n thi\u1ec7n v\u1edbi ng\u01b0\u1eddi d\u00f9ng, r\u1ea5t ph\u00f9 h\u1ee3p cho ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u \u0111\u1ea7u t\u01b0."},{"question":"C\u00f3 nh\u1eefng d\u1ea5u hi\u1ec7u t\u00edch c\u1ef1c n\u00e0o cho PTGX trong n\u0103m 2025?","answer":"PTGX c\u00f3 hai lo\u1ea1i thu\u1ed1c c\u00f9ng ti\u1ebfn g\u1ea7n \u0111\u1ebfn ph\u00ea duy\u1ec7t, tr\u1ea1ng th\u00e1i li\u1ec7u ph\u00e1p \u0111\u1ed9t ph\u00e1 cho rusfertide, ngu\u1ed3n ti\u1ec1n m\u1eb7t l\u1edbn, h\u1ee3p t\u00e1c v\u1edbi c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn v\u00e0 nhu c\u1ea7u th\u1ecb tr\u01b0\u1eddng cao cho c\u00e1c b\u1ec7nh l\u00fd m\u00e0 h\u1ecd \u0111i\u1ec1u tr\u1ecb."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>C\u00e1ch mua c\u1ed5 phi\u1ebfu Protagonist Therapeutics, Inc. (PTGX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Protagonist Therapeutics, Inc. (PTGX)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-protagonist-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Protagonist Therapeutics, Inc. (PTGX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Protagonist Therapeutics, Inc. (PTGX)\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-protagonist-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T16:51:20+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-protagonist-therapeutics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-protagonist-therapeutics\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Protagonist Therapeutics, Inc. (PTGX) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Protagonist Therapeutics, Inc. (PTGX)\",\"datePublished\":\"2025-08-25T16:51:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-protagonist-therapeutics\/\"},\"wordCount\":23,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-protagonist-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-protagonist-therapeutics\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-protagonist-therapeutics\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-protagonist-therapeutics\/\",\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Protagonist Therapeutics, Inc. (PTGX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Protagonist Therapeutics, Inc. (PTGX)\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-protagonist-therapeutics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-protagonist-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"datePublished\":\"2025-08-25T16:51:20+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-protagonist-therapeutics\/#breadcrumb\"},\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-protagonist-therapeutics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-protagonist-therapeutics\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-protagonist-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/vt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Protagonist Therapeutics, Inc. (PTGX) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Protagonist Therapeutics, Inc. (PTGX)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vt-VT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Protagonist Therapeutics, Inc. (PTGX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Protagonist Therapeutics, Inc. (PTGX)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-protagonist-therapeutics\/","og_locale":"en_US","og_type":"article","og_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Protagonist Therapeutics, Inc. (PTGX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Protagonist Therapeutics, Inc. (PTGX)","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-protagonist-therapeutics\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T16:51:20+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-protagonist-therapeutics\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-protagonist-therapeutics\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Protagonist Therapeutics, Inc. (PTGX) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Protagonist Therapeutics, Inc. (PTGX)","datePublished":"2025-08-25T16:51:20+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-protagonist-therapeutics\/"},"wordCount":23,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-protagonist-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"vt-VT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-protagonist-therapeutics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-protagonist-therapeutics\/","url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-protagonist-therapeutics\/","name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Protagonist Therapeutics, Inc. (PTGX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Protagonist Therapeutics, Inc. (PTGX)","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-protagonist-therapeutics\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-protagonist-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","datePublished":"2025-08-25T16:51:20+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-protagonist-therapeutics\/#breadcrumb"},"inLanguage":"vt-VT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-protagonist-therapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-protagonist-therapeutics\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-protagonist-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/vt\/"},{"@type":"ListItem","position":2,"name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Protagonist Therapeutics, Inc. (PTGX) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Protagonist Therapeutics, Inc. (PTGX)"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/vt\/#website","url":"https:\/\/pocketoption.com\/blog\/vt\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vt-VT"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"vt_VT","wpml_translations":{"pt_AA":{"locale":"pt_AA","id":349270,"slug":"how-to-buy-protagonist-therapeutics","post_title":"Como comprar a\u00e7\u00f5es da Protagonist Therapeutics, Inc. (PTGX) - Investimento em a\u00e7\u00f5es da Protagonist Therapeutics, Inc. (PTGX)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-protagonist-therapeutics\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/349271","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/comments?post=349271"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/349271\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media\/334072"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media?parent=349271"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/categories?post=349271"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/tags?post=349271"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}